## Abstract The biochemical features of two families with purine nucleoside phosphorylase deficiency are compared. Laboratory studies and an evaluation of kinetic and physical properties of erythrocyte purine nucleoside phosphorylase give evidence that a) the degree of abnormality in uric acid and
Lentivirus gene therapy for purine nucleoside phosphorylase deficiency
โ Scribed by Pu Liao; Ana Toro; Weixian Min; Shaun Lee; Chaim M. Roifman; Eyal Grunebaum
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 224 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1099-498X
- DOI
- 10.1002/jgm.1261
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Background
Purine nucleoside phosphorylase (PNP) deficiency causes the accumulation of toxic purine metabolites and lethal T cell immune defects, which might be corrected by expressing PNP by transplanting bone marrow (BM) cells transduced with lentiviral vectors containing the human PNP gene (lentiPNP).
Methods
Lymphocytes from a single PNPโdeficient patient as well as lymphocytes, fibroblasts and BM from PNPโdeficient (PNP โ /โ) mice were transduced with lentiPNP. Female PNP โ /โ mice were transplanted with lentiPNP transduced BM cells from male PNP โ /โ mice or normal BM.
Results
LentiPNP transduction significantly increased PNP expression in PNPโdeficient human lymphocytes, murine lymphocytes, fibroblasts and BM cells. LentiPNP transduction also significantly improved the proliferation of PNP โ /โ murine lymphocyte and survival of irradiated PNP โ /โ fibroblasts. Polymerase chain reaction analysis demonstrated efficient transduction of lentiPNP into total and lineageโdepleted BM cells grown ex vivo. LentiPNP transduced PNP โ /โ BM cells transplanted into PNP โ /โ mice expressed PNP in vivo, partially restored urinary uric acid secretion, improved thymocytes maturation, increased weight gain and extended survival of the mice. However, 12 weeks after transplant, the benefit of lentiPNP transduced cells and normal BM diminished and the percentage of engrafted donor cells decreased.
Conclusions
This shortโterm observational study provides the first in vivo proof that gene therapy may correct some of the abnormalities associated with PNP deficiency. Better gene transduction and expression, as well as improved cell engraftment, are required to further advance PNP gene therapy. Copyright ยฉ 2008 John Wiley & Sons, Ltd.
๐ SIMILAR VOLUMES
Purine nucleoside phosphorylase deficiency is an inherited disease of purine metabolism characterized clinically as combined immunodeficiency. The molecular defects have been published for 4 different alleles in 3 patients. We report four new mutations including two amino acid substitutions, A 174P
An ultramicrochemical method using radioactive substrates has been developed for the quantitation of purine nucleoside phosphorylase (NP) activity in single cells. NP activity can reproducibly be measured in both directions of the enzyme reaction. A quantitative relationship between the number of ce
We have developed a new assay for purine nucleoside phosphorylase which is based on the release of tritium when [2-3H]inosine is used as the substrate and the reaction is coupled with xanthine oxidase. After the reaction is terminated, residual [2-3H]inosine is adsorbed on charcoal and the supernata
## Abstract ## Background Pancreatic cancer remains a rapidly fatal disease. Suicide gene therapy has been shown to be an effective tool for pancreatic tumor cell destruction, but a cellโspecific gene delivery is required to limit host toxicity. The objective of this study was both to design recom